Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis | Business Wire
Teva eases debt burden with $400M tender offer as turnaround effort escalates | Fierce Pharma
Teva Pharmaceutical: Generic Market Access to Global Healthcare Industry | IntechOpen
Teva said to 'walk away' from settlement talks in US price-fixing lawsuit | The Times of Israel